Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Next-Dose Transition from Zolpidem to Lemborexant in Insomnia
NCT04009577Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd.. Started Jul 2019; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04009577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04009577.